Literature DB >> 312486

Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study.

T Finitzo-Hieber, G H McCracken, R J Roeser, D A Allen, D F Chrane, J Morrow.   

Abstract

This article reports the results of a four-year follow-up study initiated in 1970 on the long-term effects of gentamicin and kanamycin use in newborn infants. Audiometric, vestibular, and psychometric evaluations were performed on gentamicin-treated, kanamycin-treated, and untreated, matched control infants and children. No substantial sensorineural hearing loss or vestibular dysfunction was identified in these patients that could be attributed to aminoglycoside therapy. Performances on the Illinois Test of Psycholinguistic Abilities, Beery Test of Visual Motor Integration, the Peabody Picture Vocabulary Test, and on fine and gross motor examinations were comparable for the three study groups.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312486

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Single daily dose aminoglycosides in the neonatal period appear to be effective: but are they safe?

Authors:  P M Loughnan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03       Impact factor: 5.747

2.  Serum levels of gentamicin at peak and trough in neonates and infants.

Authors:  M Shahidullah; M Q Talukder; A K Chowdhury; S Ali; A Rashid
Journal:  Indian J Pediatr       Date:  1991 Mar-Apr       Impact factor: 1.967

3.  Brainstem auditory evoked response (BAER) in childhood bacterial meningitis.

Authors:  R K Kapoor; R Kumar; P K Misra; B Sharma; R Shukla; S Dwivedee
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

4.  Use of ototoxic medications in neonates-the need for follow-up hearing test.

Authors:  Tsz-Yin So
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

5.  Sensorineural hearing loss and prematurity.

Authors:  E S Marlow; L P Hunt; N Marlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

6.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

7.  Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.

Authors:  A F DeCastro; J D Place; C T Lam; C Patel
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

8.  Serum levels of ampicillin and gentamycin in neonates of varying gestational age.

Authors:  L B Dahl; K Melby; T J Gutteberg; G Størvold
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

9.  High-dose gentamicin in newborn infants: is it safe?

Authors:  Jon Widding Fjalstad; Einar Laukli; John N van den Anker; Claus Klingenberg
Journal:  Eur J Pediatr       Date:  2013-11-14       Impact factor: 3.183

Review 10.  Neurological manifestations and toxicities of the antituberculosis drugs. A review.

Authors:  M R Holdiness
Journal:  Med Toxicol       Date:  1987 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.